PATH's Initiatives in Developing Next Generation Injectables discussed at Pre-filled Syringes WC

SMi reports: Darin Zehrung, Global Program Leader, Medical Devices and Health Technologies, PATH speaking at the upcoming Pre-filled Syringes West Coast 2021
By: SMi Group
1200 X 627
1200 X 627
LONDON - May 6, 2021 - PRLog -- Patient centricity is still a key driver of the combination product industry and with updates to regulatory guidance, it is essential to keep on top of the newest changes in device regulation.

Benchmarking against the latest research and development in industry is critical in minimizing risk and ensuring the best possible product for end users.

Find out more at Pre-Filled Syringes West Coast virtual conference in June, download brochure:

Spotlight session on:
PATH's Initiatives in Developing Next Generation Injectables – The Journey from Needle Free to Micro-Array Patches
  • PATH's overview of work on injectable device and vaccine innovations, and new Center of Excellence for Microarray Patch (microneedle) technology
  • Value proposition and cost modelling of alternatives to traditional PFS
  • Clinical data to demonstrate efficacy of novel vaccine delivery devices
  • Engineering challenges and opportunities ahead

Darin Zehrung, Global Program Leader, Medical Devices and Health Technologies, PATH

Background on conference speaker:
Darin Zehrung, MBA, leads PATH's Medical Devices and Health Technologies Program. Mr. Zehrung also serves on the leadership team for PATH's Center for Vaccine Innovation and Access and serves as co-chair of the World Health Organization's Immunization Practices Advisory Committee Delivery Technologies Working Group.

Mr. Zehrung previously led PATH's portfolio in vaccine and pharmaceutical delivery technologies, helping position PATH as a globally recognized expert in delivery and packaging technologies for vaccines and essential medicines. He also led the work to establish a Center of Excellence at PATH for microarray patches and serves as the director.
Registration is live on the
Delegate rate $499 applies to pharma and biotech companies only

Proudly Sponsored by Almac, Heuft USA, Mitsubishi Gas Chemical, Novo Engineering, Nemera, Owen Mumford & Zeon Speciality Materials

For media queries please contact Jinna Sidhu at or call +44 (0)20 7827 6088


About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world's most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at

Jinna Sidhu
Posted By:*** Email Verified
Location:London City - London, Greater - England
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
SMi Group Ltd. PRs
Trending News
Most Viewed
Top Daily News

Like PRLog?
Click to Share